{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:01:56Z","timestamp":1759881716017,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013994","name":"Sociedade Brasileira de Dermatologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013994","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.abd.2019.04.006","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:54:50Z","timestamp":1575939290000},"page":"25-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of CYP2J2 polymorphism with susceptibility to psoriasis in Turkish population: a case\u2013control study"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1942-7285","authenticated-orcid":false,"given":"Y\u0131ld\u0131z","family":"Hayran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8822-3713","authenticated-orcid":false,"given":"Nuran","family":"All\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4540-6560","authenticated-orcid":false,"given":"P\u0131nar \u0130ncel","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3922-5915","authenticated-orcid":false,"given":"Tuba","family":"\u00c7andar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2019.04.006_bib0210","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","article-title":"Psoriasis \u2013 epidemiology and clinical spectrum","volume":"26","author":"Christophers","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2019.04.006_bib0215","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bjd.15021","article-title":"Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study","volume":"176","author":"Springate","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2019.04.006_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.07.073","article-title":"Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy","volume":"57","author":"Jiaravuthisan","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2019.04.006_bib0225","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00296-013-2876-z","article-title":"High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional study","volume":"34","author":"Henes","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.abd.2019.04.006_bib0230","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2019.04.006_bib0235","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.abd.2019.04.006_bib0240","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/bjd.12355","article-title":"Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis","volume":"169","author":"Dowlatshahi","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2019.04.006_bib0245","doi-asserted-by":"crossref","first-page":"11248","DOI":"10.1021\/jp204488j","article-title":"Membrane position of ibuprofen agrees with suggested access path entrance to cytochrome P450 2C9 active site","volume":"115","author":"Berka","year":"2011","journal-title":"J Phys Chem A"},{"key":"10.1016\/j.abd.2019.04.006_bib0250","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/tx700079z","article-title":"Cytochrome p450 and chemical toxicology","volume":"21","author":"Guengerich","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.abd.2019.04.006_bib0255","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1081\/DMR-120033996","article-title":"Cytochrome P450: what have we learned and what are the future issues?","volume":"36","author":"Guengerich","year":"2004","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.abd.2019.04.006_bib0260","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1194\/jlr.R800038-JLR200","article-title":"Arachidonic acid cytochrome P450 epoxygenase pathway","volume":"50Suppl","author":"Spector","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.abd.2019.04.006_bib0265","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1159\/000374011","article-title":"CYP2J2 and EETs protect against lung ischemia\/reperfusion injury via anti-inflammatory effects in vivo and in vitro","volume":"35","author":"Chen","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.abd.2019.04.006_bib0270","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10555-010-9264-x","article-title":"Cytochrome P450-derived eicosanoids: the neglected pathway in cancer","volume":"29","author":"Panigrahy","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.abd.2019.04.006_bib0275","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/03602532.2013.806537","article-title":"Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance","volume":"45","author":"Xu","year":"2013","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.abd.2019.04.006_bib0280","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2015.03.024","article-title":"CYP2J2 rs890293 polymorphism is associated with susceptibility to Alzheimer's disease in the Chinese Han population","volume":"593","author":"Yan","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.abd.2019.04.006_bib0285","first-page":"8163","article-title":"Association of CYP2J2 gene polymorphisms with ischemic stroke","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.abd.2019.04.006_bib0290","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/FPC.0b013e3283485eb2","article-title":"Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease","volume":"21","author":"Xu","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.abd.2019.04.006_bib0295","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/HJH.0b013e328333097e","article-title":"The common functional polymorphism -50G>T of the CYP2J2 gene is not associated with ischemic coronary and cerebrovascular events in an urban-based sample of Swedes","volume":"28","author":"Fava","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.abd.2019.04.006_bib0300","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/01.CIR.0000143832.91812.60","article-title":"Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2","volume":"110","author":"Spiecker","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.abd.2019.04.006_bib0305","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.pharmthera.2009.12.002","article-title":"Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases","volume":"125","author":"Zordoky","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.abd.2019.04.006_bib0310","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/FPC.0b013e32809913ea","article-title":"CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study","volume":"17","author":"Lee","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.abd.2019.04.006_bib0315","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1373\/clinchem.2006.084756","article-title":"The -50G>T polymorphism in the promoter of the CYP2J2 gene in coronary heart disease: the Ludwigshafen Risk and Cardiovascular Health study","volume":"53","author":"Hoffmann","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.abd.2019.04.006_bib0320","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2008\/626430","article-title":"A common polymorphism G-50T in cytochrome P450 2J2 gene is associated with increased risk of essential hypertension in a Russian population","volume":"24","author":"Polonikov","year":"2008","journal-title":"Dis Markers"},{"key":"10.1016\/j.abd.2019.04.006_bib0325","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.amjhyper.2005.04.019","article-title":"The prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension","volume":"18","author":"Dreisbach","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.abd.2019.04.006_bib0330","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01213011-200501000-00002","article-title":"Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension","volume":"15","author":"King","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.abd.2019.04.006_bib0335","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41440-018-0142-1","article-title":"A comprehensive study revealed SNP-SNP interactions and a sex-dependent relationship between polymorphisms of the CYP2J2 gene and hypertension risk","volume":"42","author":"Polonikov","year":"2018","journal-title":"Hypertens Res"},{"key":"10.1016\/j.abd.2019.04.006_bib0340","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/FPC.0b013e3282f313e8","article-title":"Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese population","volume":"18","author":"Zhang","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.abd.2019.04.006_bib0345","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.yjmcc.2018.08.027","article-title":"Endothelium-specific CYP2J2 overexpression improves cardiac dysfunction by promoting angiogenesis via Jagged1\/Notch1 signaling","volume":"123","author":"Zhao","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.abd.2019.04.006_bib0350","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.abd.2019.04.006_bib0355","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/bs.apha.2015.04.005","article-title":"Cytochrome P450-CYP2 family-epoxygenase role in inflammation and cancer","volume":"74","author":"Chen","year":"2015","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.abd.2019.04.006_bib0360","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1055\/s-0029-1243604","article-title":"Genetic variation in the G-50T polymorphism of the cytochrome P450 epoxygenase CYP2J2 gene and the risk of younger onset type 2 diabetes among Chinese population: potential interaction with body mass index and family history","volume":"118","author":"Wang","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.abd.2019.04.006_bib0365","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1590\/abd1806-4841.20176389","article-title":"Prevalence and heritability of psoriasis and benign migratory glossitis in one Brazilian population","volume":"92","author":"Jorge","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2019.04.006_bib0370","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/exd.13554","article-title":"Association of the novel susceptible locus rs9266150 with clinical features of psoriasis vulgaris in the Chinese Han population","volume":"27","author":"Wu","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.abd.2019.04.006_bib0375","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.jaci.2018.11.038","article-title":"PSORT Consortium HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis","volume":"143","author":"Dand","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.abd.2019.04.006_bib0380","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ng.3576","article-title":"Deep sequencing of the MHC region in the Chinese population contributes to studies of complex disease","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.abd.2019.04.006_bib0385","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1038\/jid.2015.288","article-title":"Activating CARD14 mutations are associated with generalized pustular psoriasis but rarely account for familial recurrence in psoriasis vulgaris","volume":"135","author":"Berki","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2019.04.006_bib0390","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1590\/abd1806-4841.20164016","article-title":"Variants of CARD14 gene and psoriasis vulgaris in southern Chinese cohort","volume":"91","author":"Zhu","year":"2016","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2019.04.006_bib0395","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4049\/jimmunol.1700995","article-title":"Essential role of CARD14 in murine experimental psoriasis","volume":"200","author":"Tanaka","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.abd.2019.04.006_bib0400","doi-asserted-by":"crossref","first-page":"15382","DOI":"10.1038\/ncomms15382","article-title":"Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants","volume":"8","author":"Tsoi","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.abd.2019.04.006_bib0405","doi-asserted-by":"crossref","first-page":"e11741","DOI":"10.1097\/MD.0000000000011741","article-title":"Genetic polymorphism of IL36RN in Han patients with generalized pustular psoriasis in Sichuan region of China: a case\u2013control study","volume":"97","author":"Li","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.abd.2019.04.006_bib0410","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaci.2018.06.038","article-title":"Clinical and genetic differences between pustular psoriasis subtypes","volume":"143","author":"Twelves","year":"2019","journal-title":"J Allergy Clin Immunol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059619301552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059619301552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:38:36Z","timestamp":1759793916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059619301552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0365059619301552"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2019.04.006","relation":{},"ISSN":["0365-0596"],"issn-type":[{"type":"print","value":"0365-0596"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of CYP2J2 polymorphism with susceptibility to psoriasis in Turkish population: a case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2019.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}